The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

Read more about BAP

Membership

Benefits of BAP membership include:

• FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
• Reduced registration fees for the annual Summer Meeting.
• Half price subscription to the Online CPD Resource.
• Eligibility for prizes and awards.
• Student bursaries for the BAP Summer Meeting and international conferences.
• Reduced registration fees for selected partner association events.
• 50% OFF Royal Society of Biology membership (Read more)
• BAP Newsletter.
• Voting for BAP Officers and Council (full members only).
• Being part of one of the largest national psychopharmacology associations in the world.

Meetings and Events

External Event

BAP Session

Joint Event

BAP Event

BAP Stand

All Events

Articles

Nocturnal light exposure and mood disorders
By Antonio Gonzalez
Posted on 9th December 2019

Introduction For millions of years prior to the widespread use of electricity, humans were exposed to minimal amounts of nocturnal light in comparison to modern times. During clear starry nights, light exposure was limited to around 0.001 lux, and no artificial light sources existed until the use of fire, an ability that is estimated to […]

Deciphering the biology behind psychiatric risk genes
By Simon Trent
Posted on 12th November 2019

Genetic studies that scan the genomes of psychiatric patients are becoming increasingly good at identifying ‘risk genes’ associated with disorders such as schizophrenia, autism and intellectual disability. However, we still know very little about the biological actions and pathways that are being genetically encoded within these risk genes. Understanding the biology behind the vulnerability to […]

The neuroeconomics of drug use
By Will Lawn
Posted on 15th October 2019

Neuroeconomics is an interdisciplinary research field, which emerged in the early 2000s, made up of a combination of cognitive neuroscience, psychology and behavioural economics. The primary aims of neuroeconomics are to: identify which brain regions encode subjective value (Chib, Rangel, Shimojo, & O’Doherty, 2009; Peters & Büchel, 2010); understand the brain mechanisms that underpin decision-making […]

See more articles

Media

Ravi Das
One-off ketamine dose may reduce heavy drinking, say scientists
Ravi speaks to the Guardian about a new study using ketamine to help heavy drinkers
26th November 2019

Hip Hop Psych
Welcome to the World of George the Poet
Akeem Sule and Becky Inkster (Hip Hop Psych) interview George the poet on hiphop and mental health
2nd November 2019

Andrew Mayers
5 News Special - Mental Health - Breaking the Silence
Andrew focuses specifically on fathers in a Channel 5 News programme dedicated to men’s mental health.
30th July 2019

Annabel Walsh (MQ IDEA Project)
MQ Open Mind Podcast
Helen Fisher and MQ ambassador John discuss risk for developing depression and the Identifying Depression Early in Adolescence (IDEA) Project.
29th July 2019

Barbara Sahakian
Understanding the infant-parent connection: summary interview
Barbara Sahakian interviews developmental cognitive neuroscientist Dr Victoria Leong about her research with mothers and babies exploring how they naturally synchronise during social interactions, helping babies learn from their mothers.
26th July 2019

See more media

News

See more news